Also of note, exosomal ACADM (Exo-ACADM) was strongly correlated with gemcitabine sensitivity in vivo, suggesting that it can be served as a predictor for postoperative gemcitabine chemosensitivity in patients with PC [166, 168]. Here, ACADM is linked to pachyonychia congenita.